NeuroPace, Inc. (NPCE), a medical device company, Tuesday announced three-year effectiveness data from the Post-Approval Study of its RNS (Responsive NeuroStimulation) System.
RNS System is a surgically implanted device used to treat drug-resistant focal epilepsy.
Data from the study showed an 82 percent median reduction in seizures in adults treated with RNS system.
The results were presented at the American Academy of Neurology (AAN) Annual Meeting in San Diego.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.